High level of HPV 16 and 18 DNA load in anal swabs from male and female HIV-1 infected patients

Journal of Clinical Virology

Volumn 44, Issue 4, 2009, Pages 314-317

  Poizot Martin, Isabelle ^a   Henry, Mireille ^b   Benhaim, Serge ^a   Obry Roguet, Véronique ^a   Figarella, Dominique ^b   Tamalet, Catherine ^b  

^a HÔPITAL SAINTE MARGUERITE   (France)

^b TIMONE HOSPITAL   (France)

Author keywords

Anal HPV infection; HPV 16; HPV 18; HPV load

Indexed keywords

VIRUS DNA;

ADULT; ANUS; ANUS CANCER; ARTICLE; CANCER RISK; CONTROLLED STUDY; FEMALE; GASTROINTESTINAL ENDOSCOPY; GENOTYPE; HIGH RISK POPULATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MALIGNANT TRANSFORMATION; NONHUMAN; PRIORITY JOURNAL; SQUAMOUS EPITHELIUM; VIRUS CARCINOGENESIS; VIRUS LOAD;

ADULT; ANAL CANAL; CROSS-SECTIONAL STUDIES; DNA, VIRAL; FEMALE; HIV INFECTIONS; HIV-1; HUMAN PAPILLOMAVIRUS 16; HUMAN PAPILLOMAVIRUS 18; HUMANS; MALE; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; PREVALENCE;

EID: 62749087728     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcv.2009.02.003     Document Type: Article

References (29)

1. Palefsky J.M., Holly E.A., Hogeboom J.C., Relston M.L., Da Costa M.M., Botts R., et al. Virologic, immunologic and clinical parameters in the incidence and progression of anal squamous intraepithelial lesions in HIV positive and HIV-negative homosexual men. J Acquir Immune Defic Syndr Hum Retrovirol 17 (1998) 314-319
2. Bower M., Powles T., Newsom-Davis T., Thirlwell C., Stebbing J., Mandalia S., et al. HIV-associated anal cancer. Has highly active antiretroviral therapy reduced the incidence or improved the outcome?. J Acquir Immune Defic Syndr 37 (2004) 1563-1565
3. Piketty C., Darragh T.M., Heard I., Da Costa M., Bruneval P., Kazatchkine M., et al. High prevalence of anal squamous intraepithelial lesions in HIV-positive men despite the use of highly active antiretroviral therapy. Sex Transm Dis 31 (2004) 96-99
4. Piketty C., Selinger-Leneman H., Grabar S., Duvivier C., Bonmarchand M., Abramowitz L., et al. Marked increase in the incidence of invasive anal cancer among HIV-infected patients despite treatment with combination antiretroviral therapy. AIDS 22 (2008) 1203-1211
5. Frisch M. On the etiology of anal squamous carcinoma. Dan Med Bull 49 (2002) 194-209
6. Palefsky J.M., Holly E.A., Ralston M.L., Da Costa M., and Greenblatt R.M. Prevalence and risk factors for anal human papillomavirus infection in human immunodeficiency virus (HIV)-positive and high-risk HIV-negative women. J Infect Dis 183 (2001) 383-391
7. Mayrand M.H., Duarte-Franco E., Rodrigues I., Walter S.D., Hanley J., Ferenczy A., et al. Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer. N Engl J Med 357 (2007) 1579-1588
8. Naucler P., Ryd W., Törnberg S., Strand A., Wadell G., Elfgren K., et al. Human papillomavirus and Papanicolaou tests to screen for cervical cancer. N Engl J Med 357 (2007) 1589-1597
9. Bulmans N.W.J., Berkhof J., Rozendaal L., Boeke A.J.P., Bulk S., Voorhost F.J., et al. Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial. Lancet 370 (2007) 1764-1772
10. Moberg M., Gustavsson L., and Gyllenstein U. Real-time PCR-based system for simultaneous quantification of human papillomavirus types associated with high risk of cervical cancer. J Clin Microbiol 41 (2003) 3221-3228
11. Low K.W., Yeung S.W., Cheung T.H., Siu N.S., Kahn T., and Wong Y.F. Quantitative analysis of human papillomavirus type 16 on cervical neoplasm: a study in Chinese population. J Clin Virol 34 (2005) 76-80
12. Carcopino X., Henry M., Benmoura D., Fallabregues A.S., Richet H., Boubli L., et al. Determination of HPV type 16 and 18 viral load in cervical smears of women referred to colposcopy. J Med Virol 78 (2006) 1131-1140
13. Weissenborn S.J., Funke A.M., Hellmich M., Mallmann P., Fuchs P.G., Pfister H.J., et al. J Clin Microbiol 41 (2003) 2763-2767
14. Lefevre J., Hankins C., Pourreau K., Coutlée F., and the Canadian Women's HIV study Group. Human papillomavirus type 16 viral load is increased in HIV-seropositive women with high-grade squamous intraepithelial lesions compared to those with normal cytology smears. J Clin Microbiol 42 (2004) 2212-2215
15. Yeni P. Management of patients infected by the human immunodeficiency virus. Report of an expert group: Flammarion Medicine-Sciences; 2006, p. 266-7.
16. Nicollas R., Henry M., Triglia J.M., and Tamalet C. HPV type 6 and 16 co-infection in a 11-year old girl presenting laryngeal papillomatosis. J Clin Virol 40 (2007) 252-254
17. Palefsky J.M., Holly E.A., Ralston E.A., and Jay N. Prevalence and risk factors for human papillomavirus infection of the anal canal in human immunodeficiency virus (HIV) positive and HIV-negative homosexual men. J Infect Dis 177 (1998) 361-367
18. Palefsky J.M., Holly E.A., Efirdc J.T., Da Costa M., Jay N., Berry J.M., et al. Anal intraepithelial neoplasia in the highly active antiretroviral therapy era among HIV-positive men who have sex with men. AIDS 19 (2005) 1407-1414
19. Sirera G., Videla S., Pinol M., Canada M.P., Llatjos M., Ballesteros A.L., et al. High prevalence of human papillomavirus infection in the anus, penis and mouth in HIV-positive men. AIDS 20 (2006) 1201-1204
20. Orlando G., Tanzi E., Beretta R., Amendola A., Fasolo M.M., Bianchi S., et al. Human Papillomavirus genotypes and anal-related lesions among HIV-1 infected men in Milan, Italy. J Acquir Immune Defic Syndr 47 (2007) 129-131
21. Woodman C.B., Collins S., Winter H., Bailey A., Ellis J., Prior P., et al. Natural history of cervical human papillomavirus infection in young women: a longitudinal cohort study. Lancet 357 (2001) 1831-1836
22. Liaw K.L., Glass A.G., Manos M.M., Greer C.E., Scott D.R., Sherman M., et al. Detection of human papillomavirus DNA in cytologically normal women and subsequent cervical squamous intraepithelial lesions. J Natl Cancer Inst 91 (1999) 954-960
23. Bachtiary B., Obermair G., Dreier B., Bimer P., Breitenecker G., Knocke T.H., et al. Impact of multiple HPV infection on response to treatment and survival in patients receiving radical radiotherapy for cervical cancer. Int J Cancer 102 (2002) 237-243
24. Van der Graaf Y., Molijn A., Doornewaard H., Quint W., Van Doorn L.J., and Van den Tweel J. Human Papillomavirus and the long-term risk of cervical neoplasia. Am J Epidemiol 156 (2002) 158-164
25. Dalstein V., Riethmuller D., Pretet J.L., Le Bail Carval K.L., Sautière J.L., Carbillet J.P., et al. Persistence and load of high-risk HPV are predictors for development of high-grade cervical lesions: a longitudinal French cohort study. Int J Cancer 106 (2003) 396-403
26. Van Duin M., Snijders P.J., Schrijnrmaakers H.F., Voohorst F.J., Rozendaal L., Nobbenhuis M.A., et al. Human papillomavirus 16 load in normal and abnormal cervical scrapes: an indicator of CINII/III and viral clearance. Int J Cancer 98 (2002) 590-595
27. Drobacheff C., Dupont P., Mougin C., Bourezane Y., Challier B., Fantoli M., et al. Anal human papillomavirus DNA screening by Hybrid Capture IITM in human immunodeficiency virus-positive patients with or without anal intercourse. Eur J Dermatol 13 (2003) 367-371
28. Pierangeli A., Scagnolari C., Degener A.M., Bucci M., Ciardi A., Riva E., et al. Type-specific human papillomavirus-DNA load in anal infection in HIV-positive men. AIDS 22 (2008) 1929-1935
29. ink4a expression decreases during imiquimod treatment of anal intraepithelial neoplasia in human immuno-deficiency virus-infected men and correlates with the decline of lesional high-risk human papillomavirus DNA load. Br J Dermatol 157 (2007) 523-530